Prulifloxacin + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Gastroenteritis in Adult Travelers
Conditions
Acute Gastroenteritis in Adult Travelers
Trial Timeline
Aug 1, 2006 → Mar 1, 2008
NCT ID
NCT00392574About Prulifloxacin + Placebo
Prulifloxacin + Placebo is a phase 3 stage product being developed by Merck for Acute Gastroenteritis in Adult Travelers. The current trial status is completed. This product is registered under clinical trial identifier NCT00392574. Target conditions include Acute Gastroenteritis in Adult Travelers.
What happened to similar drugs?
20 of 20 similar drugs in Acute Gastroenteritis in Adult Travelers were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00392574 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Gastroenteritis in Adult Travelers